REVISIED LABELING FOR ADX BENZODIAZEPINES— 510(k) K880014
Substantially EquivalentAbbott Laboratories
FDA 510(k) clearance K880014 for REVISIED LABELING FOR ADX BENZODIAZEPINES, Substantially Equivalent on 1988-02-11. Applicant: Abbott Laboratories.
Clearance details
- Applicant
- Abbott Laboratories
- Product code
- Code JXM
- Advisory panel
- Clinical Toxicology
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Traditional
- Location
- Abbott Park, IL, US
Data sourced from openFDA. This site is unofficial and independent of the FDA.